2020
DOI: 10.20944/preprints202004.0101.v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

The Powerful Immune System Against Powerful COVID-19: A Hypothesis

Abstract: On March 11, 2020, the World Health Organization declared the coronavirus outbreak a pandemic. Since December 2019, the world has experienced an outbreak of coronavirus disease 2019 (COVID-19). Epidemiology, risk factors, and clinical characteristics of patients with COVID-19 have been reported but the factors affecting the immune system against COVID-19 have not been well described. In this article, we provide a novel hypothesis to describe how an increase in cellular adenosine triphosphate (c-ATP) can potent… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
21
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 17 publications
(22 citation statements)
references
References 3 publications
1
21
0
Order By: Relevance
“…Oestrogens suppress the escalation phase of the immune response that leads to increased cytokine release. 91 Authors also showed that female mice treated with an oestrogen receptor antagonist died at close to the same rate as male mice. 92…”
Section: Discussionmentioning
confidence: 97%
“…Oestrogens suppress the escalation phase of the immune response that leads to increased cytokine release. 91 Authors also showed that female mice treated with an oestrogen receptor antagonist died at close to the same rate as male mice. 92…”
Section: Discussionmentioning
confidence: 97%
“…The finding of lower incidence of Covid-19 with BCG coverage and endemicity of malaria and TB might not be merely circumstantial evidence.When a virus infects cells of a body, the body immediately mounts a non-specific innate response consisting of neutrophils, macrophages and dendritic cells which slow the progress of the virus and may even prevent the development of symptoms. COVID-19 34 may inhibit the expression of IFN-1 to overcome the immune response like its predecessor SARS-CoV Type I interferons are produced by immune cells in response to viruses and they act on infected as well as uninfected cells, activating enzymes that cause the degradation of viral nucleic acids and the inhibition of viral of replication, causing the induction of a kind of ‘antiviral state’ 35 . Type 1 IFN is well known for its antiviral activity and stimulation of effector T cell responses 36 .…”
Section: Discussionmentioning
confidence: 99%
“…Additionally, individuals between 56-and 65-years-old presented more severe depressive and anxiety symptoms than other age groups. Studies and reports showed a relatively low incidence risk of COVID-19 for young people but a very high mortality risk for elders [34,35].…”
Section: Discussionmentioning
confidence: 96%